CABAZITAXEL FOR INJECTION
FORMATIVE PHARMA INC.
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of CABAZITAXEL FOR INJECTION in Canada?
A shortage of CABAZITAXEL FOR INJECTION 60MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated November 5, 2026), but it has not started yet.
When will CABAZITAXEL FOR INJECTION be available again?
No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
CABAZITAXEL FOR INJECTION
SANDOZ CANADA INCORPORATED
What this means
Does this mean my pharmacy is already out of stock?
No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.
What should I do?
This product is usually given in a hospital or clinic, where the pharmacy team manages supply. If you're scheduled to receive it, ask your care team.
DIN
02553791
Strength
60MG
Dosage Form
SOLUTION
Route
INTRAVENOUS
Active Ingredient
CABAZITAXEL
Tier
Unrated
Last Updated
2026-11-05
Reason for Shortage
Other (Please describe in comments)
Other Products from FORMATIVE PHARMA INC.
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
250MG · DIN 02539586
7.5MG · DIN 02536714
45MG · DIN 02553783
250MG · DIN 02536293
500MG · DIN 02537168
10MG · DIN 02534827
20MG · DIN 02547856